Mesenkia Technologies

Developer of next-generation single domain antibodies for glioblastoma treatment

placeUppsala, Uppsala County, Sweden calendar_todayFounded 2023 language mesenkia.com

Social engagement

Social engagement: 238 social following, 7 posts in the last 12 months — top 10% of its industry.

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%

Recent activity

19 Dec 2025
Milestone
anniversary
28 Nov 2025
Recognition
member
3 Oct 2025
Event
NLSdays in Gothenburg
Coming soon